isradipine has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 2 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with the new calcium antagonist isradipine significantly reduced diastolic blood pressure to less than 90 mm Hg in 64% of fourteen blacks with mild or moderately severe essential hypertension." | 5.06 | The new calcium antagonist isradipine. Effect on blood pressure and the left ventricle in black hypertensive patients. ( Carr, AA; Prisant, LM, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carr, AA | 1 |
Prisant, LM | 1 |
Ferry, DR | 1 |
Kaumann, AJ | 1 |
1 trial available for isradipine and Cardiomyopathy, Hypertrophic Obstructive
Article | Year |
---|---|
The new calcium antagonist isradipine. Effect on blood pressure and the left ventricle in black hypertensive patients.
Topics: Antihypertensive Agents; Black People; Blood Pressure; Calcium Channel Blockers; Cardiomyopathy, Hyp | 1990 |
1 other study available for isradipine and Cardiomyopathy, Hypertrophic Obstructive
Article | Year |
---|---|
Relationship between beta-adrenoceptors and calcium channels in human ventricular myocardium.
Topics: Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Female; Humans; In Vitro Techniques; Iodoben | 1987 |